Cuộc họp công bố kết quả kinh doanh Q2 2026 của Rockwell Medical (RMTI): Doanh thu tăng 11%, biên lợi nhuận mở rộng
Doanh thu quý II/2026 của Rockwell Medical tăng 11% lên 17,8 triệu USD, biên lợi nhuận gộp đạt 18%, và ban lãnh đạo đã tái khẳng định dự báo cho cả năm.
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.